With optimistic projections of a COVID-19 vaccine on the horizon sometime in late 2020 or early 2021 (see: Pfizer and Moderna beginning Phase 3 trials and Oxford’s ‘so-far’ successful trials) there is another factor often not talked about in the fight against COVID-19.
We might be tackling the biological issue with the development of vaccines, but the societal issues of actually administering and distributing the vaccine are yet to be widely discussed. In the United States, if we are debating on whether or not to wear a mask… then how do we expect those same individuals to react to being asked to take a vaccine? Distribution and prioritization of the vaccine as well pose a cumbersome challenge; if PPE was difficult to distribute, how can we expect a vaccine to be distributed easier than protective clothing equipment.
Will we end up having vaccination safe zones? We need to start planning and beginning to campaign for the vaccine as the ‘plandemic’ and anti-vax movement has had a large head start.